Exosens Secures €140M from EIB for Night Vision Technologies
French specialist in night vision and imaging technologies for defense announced on Thursday that it has secured a €140 million credit facility from the European Investment Bank (EIB). This financing, backed by the European Commission's InvestEU program, is intended to support the group's research, development, and innovation activities, as well as its industrial investments in the European defense, surveillance, and civilian sectors.
Financing Aligned with European Strategic Priorities
Exosens states that this operation is in line with the EIB's strategic priorities for technological innovation and strengthening Europe's industrial sovereignty and defense capabilities. The group emphasizes that the financing recognizes 'its technological leadership and strategic role within the European industrial ecosystem.' The credit facility, with a maturity of up to seven years, aims to finance investments in photonic technologies for night vision and imaging applications, particularly in the defense and surveillance sectors. It also aims to enhance the group's financial flexibility to support its medium-term growth strategy.
Investments in France and Europe
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The investments supported by this financing will involve several of the group's production and research sites, including its state-of-the-art facility in Brive-la-Gaillarde, France. Exosens currently has 12 sites across Europe and North America, employing more than 2,000 staff members. The group outlines its position as a trusted supplier of critical, high-value-added photonic solutions, free from ITAR (International Traffic in Arms Regulations) constraints, serving the European defense ecosystem.
Nous avons constaté une forte croissance et une rentabilité.
Exosens continue de bénéficier d'une forte demande pour ses solutions de vision nocturne et d'imagerie numérique.
Risks mentioned
Tensions géopolitiques croissantes pourraient influencer la demande.
Risques liés à l'expansion des capacités de production.
Opportunities identified
Renforcement de la dynamique commerciale dans le marché de la défense.
Recours à des technologies optroniques avancées en pleine expansion.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
